Skip to main content
OpenTrials

Clinical trial condition

Urologic Neoplasms

Explore clinical trials studying Urologic Neoplasms. Study availability and eligibility vary by location and protocol.

2,957 public trials 633 recruiting studies
Refine in advanced search Browse all conditions

Urologic Neoplasms trial results

Completed

Microsatellite Analysis of Urinary Sediment in Detecting Bladder Cancer

NCT00095589

Conditions
Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham Birmingham, Alabama, United States
  • Stanford Cancer Center Stanford, California, United States
  • University of Chicago Cancer Research Center Chicago, Illinois, United States
  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States
View all 13 locations
View Trial Details
Completed

A Phase 1b Trial in Patients With Renal Cell Cancer

NCT01258348

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Indianapolis, Indiana, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Greenville, South Carolina, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. The Woodlands, Texas, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Norfolk, Virginia, United States
View Trial Details
Completed

Axitinib (AG 013736) As Second Line Therapy For Metastatic Renal Cell Cancer

NCT00678392

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Kidney Diseases, +8 more
Locations
  • East Valley Hematology and Oncology Medical Group Burbank, California, United States
  • Maurice Berkowtiz, MD Burbank, California, United States
  • Agajanian Institute of Oncology and Hematology Downey, California, United States
  • Los Angeles Hematology/Oncology Medical Group Glendale, California, United States
View all 294 locations
View Trial Details
Completed

A Study With Tasquinimod Treating Patients With Hepatocellular, Ovarian, Renal Cell and Gastric Cancers

NCT01743469

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced or Metastatic Gastric Carcinoma, +38 more
Locations
  • Antwerp University Hospital, Wilrijkstraat 10 Edegem, Belgium
  • Ghent University Hospital, 1K12 IE, De Pintelaan 185 Ghent, Belgium
  • Leuven cancer institute (LKI), Herestraat Leuven, Belgium
  • Juravinski Cancer Centre, 699 Concession St Hamilton, Ontario, Canada
View all 24 locations
View Trial Details

Related conditions